Sullivan, S. A., Shlesinger, A. S., Singh, K., Ashar, P., & Dunn, J. P. (2026). Unaddressed implications of the FDA's 2026 guidance on wellness devices. Nature Biomedical Engineering. https://doi.org/10.1038/s41551-026-01727-2

Sullivan, Stephanie A., Anita Silver Shlesinger, Karnika Singh, Perisa Ashar, and Jessilyn P. Dunn. “Unaddressed implications of the FDA's 2026 guidance on wellness devices.” Nature Biomedical Engineering, June 2026. https://doi.org/10.1038/s41551-026-01727-2.

Sullivan SA, Shlesinger AS, Singh K, Ashar P, Dunn JP. Unaddressed implications of the FDA's 2026 guidance on wellness devices. Nature biomedical engineering. 2026 Jun;

Sullivan, Stephanie A., et al. “Unaddressed implications of the FDA's 2026 guidance on wellness devices.” Nature Biomedical Engineering, June 2026. Epmc, doi:10.1038/s41551-026-01727-2.

Sullivan SA, Shlesinger AS, Singh K, Ashar P, Dunn JP. Unaddressed implications of the FDA's 2026 guidance on wellness devices. Nature biomedical engineering. 2026 Jun;